Showing 161-170 of 4814 results for "".
The War Zone: Private Practice
https://practicaldermatology.com/series/the-practical-dermatology-podcast/the-war-zone-private-practice/54847/The War Zone: Private PracticePractical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, and Editorial Board member Collin Blattner, DO, FAAD, discuss strategies for building a successful private practice in the era of private equity, as well as the challenges associated with it.Unmet Needs in Atopic Dermatitis Management
https://reachmd.com/programs/dermatology-hub-neuroimmune-network/unmet-needs-in-atopic-dermatitis-management/37145/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, a board-certified dermatologist in San Diego, California, and Director of Clinical Dermatology at Therapeutics Clinical Research, says the most pressing unmet needs in atopic dermatitis management today involve the targets of therapyWorking up Prurigo Nodularis and Getting to the Source of Itch
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37146/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, a board-certified dermatologist in San Diego, California, and Director of Clinical Dermatology at Therapeutics Clinical Research, discusses how to identify and address the source of itch in prurigo nodularis cases.Analyzing Safety Data From Level Up
https://practicaldermatology.com/series/the-practical-dermatology-podcast/analyzing-safety-data-from-level-up/33944/The latest news and updates, plus Matthew Zirwas, MD, FAAD, joins Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, to discuss the importance of the Week 16 safety data from the Level Up study on upadacitinib. Silverberg JI, Bunick CG, et al. Efficacy and safety of upadacitinib versuJournal Club: Dupilumab and Risk of Malignancy
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-dupilumab-and-risk-of-malignancy/32398/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, speaks with Matthew Zirwas, MD, about the Journal of Allergy and Clinical Immunology: In Practice article "Risk of malignancy associated with use of dupilumab versus other treatments in atopic dermatitis patients: A national databasePhysician Spotlight: Chérie M. Ditre, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-chrie-m-ditre-md/20740/The skinny on what's new and exciting in cosmetic dermatology.CSF After Dark
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/csf-after-dark/20386/ICYMI: Updates from behind the scenes at the 10th Annual Cosmetic Surgery Forum.Make Your Mark: Formulate a Product Line
https://practicaldermatology.com/topics/practice-management/make-your-mark-formulate-a-product-line/20023/Dispensing skincare offers benefits to your practice and your patients. Joel Schlessinger, MD discusses his journey with his son to developing their own product formulation and offers insights and encourages colleagues to use their unique talents to do the same.Advanced Laser Techniques from Cosmetic Surgery Forum 2019
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/advanced-laser-techniques-1/20125/What are the most promising energy-based options in laser technology. CSF faculty members, Jill Waibel, MD, Neil Sadick, MD, Manjula Jegasothy, MD, an Barry Lycka, MD offer fresh takes on the device field and share tips for optimizing outcomes.Three's the Charm
https://practicaldermatology.com/topics/practice-management/threes-the-charm/20585/Expert injectors discuss the promise and perils of Botox Cosmetic's third nod.